Table 1. The characteristics of the 381 patients grouped by SII, NLR, PLR and PNI.
| Variables | Cases (number, %) | SII (number) | P value | NLR (number) | P value | PLR (number) | P value | PNI (number) | P value | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 381 (100) | <682.98 | ≥682.98 | <2.69 | ≥2.69 | <118.74 | ≥118.74 | <49.95 | ≥49.27 | ||||||
| Gender | 0.895 | 0.436 | 0.903 | 0.101 | ||||||||||
| Male | 294 (77.2) | 202 | 92 | 194 | 100 | 142 | 152 | 113 | 181 | |||||
| Female | 87 (22.8) | 61 | 26 | 62 | 25 | 43 | 44 | 25 | 62 | |||||
| Age (years) | 0.377 | 0.231 | 1 | 0.001 | ||||||||||
| ≤60 | 194 (50.9) | 138 | 56 | 136 | 58 | 94 | 100 | 54 | 140 | |||||
| >60 | 187 (49.1) | 125 | 62 | 120 | 67 | 91 | 96 | 84 | 103 | |||||
| Smoking | 0.401 | 0.123 | 0.504 | 0.049 | ||||||||||
| Ever | 266 (69.8) | 180 | 86 | 172 | 94 | 126 | 140 | 105 | 161 | |||||
| Never | 115 (30.2) | 83 | 32 | 84 | 31 | 59 | 56 | 33 | 82 | |||||
| Drinking | 0.119 | 0.066 | 0.588 | 0.013 | ||||||||||
| Ever | 253 (66.4) | 169 | 84 | 162 | 91 | 120 | 133 | 103 | 35 | |||||
| Never | 128 (33.6) | 94 | 34 | 94 | 34 | 65 | 63 | 150 | 93 | |||||
| Tumor length | 0.001 | 0.001 | 0.001 | 0.002 | ||||||||||
| ≤4 | 221 (58.0) | 174 | 47 | 166 | 55 | 124 | 97 | 65 | 156 | |||||
| >4 | 160 (42.0) | 89 | 71 | 90 | 70 | 61 | 99 | 73 | 87 | |||||
| Tumor type | 0.136 | 0.001 | 0.027 | 0.291 | ||||||||||
| LCNEC | 143 (37.5) | 90 | 53 | 82 | 61 | 60 | 83 | 57 | 86 | |||||
| SCLC | 181 (47.5) | 132 | 49 | 126 | 55 | 101 | 80 | 65 | 116 | |||||
| AC | 57 (15.0) | 41 | 16 | 48 | 9 | 24 | 33 | 16 | 41 | |||||
| T stage | 0.001 | 0 | 0.001 | 0.001 | ||||||||||
| T1 | 128 (33.6) | 113 | 15 | 106 | 22 | 81 | 47 | 33 | 95 | |||||
| T2 | 150 (39.4) | 96 | 54 | 91 | 59 | 72 | 78 | 59 | 91 | |||||
| T3 | 61 (16.0) | 35 | 26 | 38 | 23 | 22 | 39 | 20 | 41 | |||||
| T4 | 42 (11.0) | 19 | 23 | 21 | 21 | 10 | 32 | 26 | 16 | |||||
| N stage | 0.077 | 0.123 | 0.745 | 0.896 | ||||||||||
| N0 | 190 (49.9) | 140 | 50 | 137 | 53 | 96 | 94 | 71 | 119 | |||||
| N1 | 86 (22.6) | 59 | 27 | 53 | 33 | 40 | 46 | 30 | 56 | |||||
| N2 | 105 (27.6) | 64 | 41 | 66 | 39 | 49 | 56 | 37 | 68 | |||||
| M stage | 1 | 0.6 | 0.359 | 0.623 | ||||||||||
| M0 | 377 (99.0) | 260 | 117 | 254 | 123 | 182 | 195 | 136 | 241 | |||||
| M1 | 4 (1.0) | 3 | 1 | 2 | 2 | 3 | 1 | 2 | 2 | |||||
| TNM stage | 0.001 | 0.007 | 0.038 | 0.135 | ||||||||||
| I | 142 (37.3) | 111 | 31 | 107 | 35 | 81 | 61 | 48 | 94 | |||||
| II | 93 (24.4) | 68 | 25 | 66 | 27 | 42 | 51 | 27 | 66 | |||||
| III | 142 (37.3) | 81 | 61 | 81 | 61 | 59 | 83 | 61 | 81 | |||||
| IV | 4 (1.0) | 3 | 1 | 2 | 2 | 3 | 1 | 2 | 2 | |||||
| Operation time (min) | 0.293 | 0.367 | 0.918 | 0.127 | ||||||||||
| <180 | 294 (77.2) | 207 | 87 | 201 | 93 | 138 | 156 | 100 | 194 | |||||
| ≥180 | 87(22.8) | 56 | 31 | 55 | 32 | 47 | 40 | 38 | 49 | |||||
| Intraoperative blood loss (mL) | 0.314 | 0.061 | 0.273 | 0.519 | ||||||||||
| <200 | 216 (56.7) | 154 | 62 | 154 | 62 | 104 | 112 | 75 | 141 | |||||
| ≥200 | 165 (43.3) | 109 | 56 | 102 | 63 | 81 | 84 | 63 | 102 | |||||
| Treatment | 0.419 | 0.363 | 0.669 | 0.579 | ||||||||||
| Surgery only | 247 (64.8) | 174 | 73 | 170 | 77 | 122 | 125 | 87 | 160 | |||||
| Surgery with adjuvant therapy | 134 (35.2) | 89 | 45 | 86 | 48 | 63 | 71 | 51 | 83 | |||||
NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; SII, systemic immune-inflammation index; PNI, prognostic nutritional index; LCNEC, large cell neuroendocrine carcinoma; SCLC, small cell lung cancer; AC, atypical carcinoid